Antimicrobial Resistance: A Threat that Calls for Non-Conventional Strategies

by ISGlobal - Instituto de Salud Global de Barcelona

ISGlobal researchers publish a review on the most promising strategies and organise, in collaboration with Biocat and “la Caixa”, a B-debate on the topic

Read more

Researchers at IDIBELL-ICO describe a new resistance mechanism to therapies that prevent the formation of blood vessels

by Hospital Universitari de Bellvitge

The mechanism does not activate the reduction of oxygen in the cells of the tumor, contrary to what common drugs, called anti-angiogenic, usually cause

Read more

Two promising avenues in the fight against antibiotic resistance

by Institut de Bioenginyeria de Catalunya

IBEC’s Bacterial infections: antimicrobial therapies group have published two papers offering new hope in the urgent search for antimicrobials.

Read more

Bioinformatics brings to light new combinations of drugs to fight breast cancer

by IRB Barcelona - Instituto de Investigación Biomédica

A bioinformatics analysis of pairing 64 drugs used to treat breast cancer allows researchers at IRB Barcelona to identify 10 previously untested combinations with potential to tackle resistance to bre...

Read more

The European project ANTI-SUPERBUGS PCP kicks off to join the fight against superbugs

by IBEC - Institut de Bioenginyeria de Catalunya

The microbiology services play a fundamental role in the identification and monitoring of "superbugs", but time of diagnosis remains as an unresolved issue that affects all prevention and treatment st...

Read more

CNIO scientists have discovered a specific molecular biomarker for malignant melanoma

by CNIO - Centro Nacional de Investigaciones Oncológicas

Melanomas can be distinguished from other tumours by the partial loss of the ATG5 autophagy gene that increases their aggressiveness and resistance to existing drugs. These data support the use of ATG...

Read more

The absence of a protein points out the prognosis of liver cancer patients

by CIMA - Centro de Investigación Médica Aplicada

Using proteome technology, CIMA researchers have established the mechanisms that favor tumor growth and resistance to chemotherapy

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...


Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Not all 'good'cholesterol is healthy

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

The work shows that people with large HDL particles have an increased ...

Photos Stream